GlobeNewswire•April 1, 2020 VANCOUVER, British Columbia, April 01, 2020 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQX: WMLLF; SSE: WMLCL; Frankfurt: EJZN), provides the public and its shareholders with a corporate update. A Message from Wealth’s CEO: “I write this message in order to reach out to all of our…
DetailsLakewood, Colorado – March 18, 2020 Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading uranium producer in the U.S., is pleased to announce that it will host an investor webcast at 9:00 a.m. ET on Friday, March 20, 2020. Energy Fuels’ Senior Management invites investors and other stakeholders…
DetailsLAKEWOOD, CO, March 16, 2020 /CNW/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”) today reported its financial results for the year ended December 31, 2019. The Company’s annual report on Form 10-K has been filed with the U.S. Securities and Exchange Commission (“SEC“) and may be viewed on the Electronic Document Gathering…
DetailsGlobeNewswire•March 17, 2020 ED Drug Market Expected to Reach US$6.5B by 2025 OXNARD, Calif., March 17, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No. ZL201480039313.6. The new patent covers the loading of high amounts of active drug on an oral thin film using…
DetailsGlobeNewswire•February 12, 2020 Vanguard Scientific builds customer trust with CUREinside™ patented methods LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with Vanguard Scientific Systems, Inc., a premier provider of equipment, systems and performance solutions servicing the botanical extraction…
DetailsPR Newswire•February 11, 2020 LAKEWOOD, CO, Feb. 11, 2020 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading uranium producer in the U.S., applauds President Trump for yesterday announcing a budget that seeks $150 million per year over the next 10 years (totaling $1.5 billion over that…
DetailsGlobeNewswire•February 5, 2020 CURE debuts “CUREinside” quality mark on the packaging of ReLeaf Europe’s sublingual tinctures and new topical cream product lines OXNARD, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, announced today that it has signed an exclusive licensing agreement with ReLeaf Europe, one of…
DetailsIndustry veteran brings 40 year of experience to support CURE’s rapid growth OXNARD, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it has named John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience…
Details